CSIMarket Company Name, Ticker, Customers, else..
 
Qsam Biosciences Inc   (APGR)
 

Qsam Biosciences Inc's Suppliers Performance

APGR's Supply Chain



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

 
APGR Costs vs Sales of Suppliers Growth Qsam Biosciences Inc's Suppliers recorded an increase in sales by 3.42 % year on year in Q4 2023, sequentially sales grew by 16.48 %, Qsam Biosciences Inc's cost of sales deteriorated by -75.29 % year on year, relative to one quarter ago cost of sales fell by -17.48 % in Q4.

• More on APGR Suppliers



Qsam Biosciences Inc's Suppliers recorded an increase in sales by 3.42 % year on year in Q4 2023, sequentially sales grew by 16.48 %, Qsam Biosciences Inc's cost of sales deteriorated by -75.29 % year on year, compare to one quarter ago cost of sales fell by -17.48 % in Q4.

• More on APGR Suppliers




Qsam Biosciences Inc's Comment on Supply Chain


The company sources Samarium-153 from the Missouri University Research Reactor (MURR) for animal studies, a Single Patient Investigational New Drug (IND) at the Cleveland Clinic, and ongoing clinical trials. The National Energy Technology Laboratory (NETL) supplies irradiated Samarium-153, primarily for dosing patients at the Houston, Texas clinical trial site. The company intends to qualify additional suppliers for both raw non-irradiated Samarium and its irradiation to diversify its supply chain and reduce business risks.

Qsam Biosciences Inc's Comment on Supply Chain


The company sources Samarium-153 from the Missouri University Research Reactor (MURR) for animal studies, a Single Patient Investigational New Drug (IND) at the Cleveland Clinic, and ongoing clinical trials. The National Energy Technology Laboratory (NETL) supplies irradiated Samarium-153, primarily for dosing patients at the Houston, Texas clinical trial site. The company intends to qualify additional suppliers for both raw non-irradiated Samarium and its irradiation to diversify its supply chain and reduce business risks.


APGR's Suppliers Net Income grew by APGR's Suppliers Net margin grew in Q4 to
20.86 % 20.33 %
APGR's Suppliers Net Income grew by 20.86 %


APGR's Suppliers Net margin grew in Q4 to 20.33 %


Qsam Biosciences Inc's Suppliers Sales Growth in Q4 2023 by Industry

Suppliers from Chemical Manufacturing Industry -0.73 %   
Suppliers from Chemicals - Plastics & Rubber Industry -9.19 %   
Suppliers from Aluminum Industry -2.66 %   
Suppliers from Iron & Steel Industry -26.23 %   
Suppliers from Metal Mining Industry -18.6 %   
Suppliers from Miscellaneous Fabricated Products Industry -6.42 %   
Suppliers from Paper & Paper Products Industry      4.13 %
Suppliers from Aerospace & Defense Industry      12.34 %
Suppliers from Miscellaneous Manufacturing Industry      9.27 %
Suppliers from Industrial Machinery and Components Industry      9.78 %
Suppliers from Conglomerates Industry      44.36 %
Suppliers from Apparel, Footwear & Accessories Industry      0.47 %
Suppliers from Electronic Parts & Equipment Industry -33.93 %   
Suppliers from Auto & Truck Parts Industry -18.39 %   
Suppliers from Electric & Wiring Equipment Industry -33.03 %   
Suppliers from Personal & Household Products Industry -15.02 %   
Suppliers from Property & Casualty Insurance Industry      19.46 %
Suppliers from Medical Equipment & Supplies Industry    
Suppliers from Laboratory Analytical Instruments Industry      323.95 %
Suppliers from Broadcasting Media & Cable TV Industry -7.95 %   
Suppliers from Professional Services Industry      3.42 %
Suppliers from Communications Equipment Industry -12.82 %   
Suppliers from IT Infrastructure Industry      10.02 %
Suppliers from Scientific & Technical Instruments Industry -0.47 %   
Suppliers from Semiconductors Industry -10.24 %   
Suppliers from Consumer Electronics Industry      47.07 %
     





APGR's vs. Suppliers, Data

(Revenue and Income for Trailing 12 Months, in Millions of $, except Employees)



COMPANY NAME MARKET CAP REVENUES INCOME EMPLOYEES
Qsam Biosciences Inc 0.00 0.00 -5.13 5
Genuine Parts Co 17,863.88 25,070.54 32.77 65,000
Novo Integrated Sciences Inc 0.07 12.74 -16.13 31
Optical Cable Corporation 125.85 82.58 2.56 201
Orbital Infrastructure Group Inc 42.17 332.15 -263.15 60
Omnitek Engineering Corp 0.00 0.95 0.03 6
SUBTOTAL 4,008,757.96 1,932,030.49 260,879.86 4,677,886
82 more Suppliers available

Sign in to see all suppliers for Qsam Biosciences Inc .

Sign In Create Free Account


Sources: Qsam Biosciences Inc 's official press releases and regulatory filings; CSIMarket.com's supply-chain research; and the financial filings and press releases of other companies cited in this report.
Updated on:
For your research, we’ve provided nine additional tables on Qsam Biosciences Inc ’s suppliers.
You can find them in the navigation menu under Suppliers.
To download the tables, please subscribe.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.